Search - tctmd.com

Displaying 241 - 260 of 963

Sort: Relevancy | Date

Presentation TCT 2017

TCT 94: Safety and Efficacy of the Combo Bioegineered Stent in an All-Comer PCI Cohort - Results From the Mascot Postmarketing Registry

Presenter: Francesco Prati, Renu Virmani, Antonio Colombo

October 31, 2017

Presentation TCT 2017

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Standard vs Novel DES and DAPT Duration

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Ajay J. Kirtane

October 31, 2017

Presentation TCT 2017

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Stephan Achenbach, Jacques J. Koolen, Ron Waksman

October 31, 2017

Presentation TCT 2017

TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings

Presenter: Francesco Prati, Renu Virmani, Abraham Tzafriri, MD

October 31, 2017

Presentation TCT 2017

XINSORB: A Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Thomas F. Luscher, Junbo Ge

October 31, 2017

Presentation TCT 2017

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Appropriate Patients and DAPT Duration

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Marie-Claude Morice

October 31, 2017

Presentation TCT 2017

ABSORB PSP: Impact of Technique on Early and Late Outcomes Following Coronary Bioresorbable Scaffold Implantation

Presenter: Y. S. Chandrashekhar, David J. Moliterno, Gregg W. Stone

October 31, 2017

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

TCT 12: Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis Multistudy Registry Results

Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Stephen G. Ellis

October 31, 2017

Presentation TCT 2017

RECAP: A Sham-Controlled Randomized Trial of Radiation Protection in Patients Undergoing PCI

Presenter: David P. Faxon, Joseph A. Hill, Wieneke Vlastra

October 31, 2017

Presentation TCT 2017

TCT 9: Absorb Bioresorbable Vascular Scaffold vs Everolimus-Eluting Metallic Stent in Small Vessel Disease -A Propensity Matched Analysis of COMPARE II, RAI, and MAASSTAD-ABSORB Prospective Studies

Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Alberto Barioli, MD

October 31, 2017

Presentation TCT 2017

DEBATE-SFA: A Randomized Trial of a BMS With or Without Cilostazol vs a DES in Patients With Femoropopliteal Disease

Presenter: David P. Faxon, Joseph A. Hill, Yusuke Miyashita

October 31, 2017

Presentation TCT 2017

TCT 10: Mechanisms of Very Late Bioresorbable Scaffold Thrombosis Assessed by Optical Coherence Tomography - Insights From the International INVEST Registry

Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Lorenz Raber

October 31, 2017

Presentation TCT 2017

RECOVERY: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating vs a Polymer-Free Metallic DES in Patients With Coronary Artery Disease

Presenter: David P. Faxon, Joseph A. Hill, Ling Tao

October 31, 2017

Presentation TCT 2017

ABSORB II: 4-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Robert-Jan van Geuns, Bernard R. Chevalier

October 31, 2017

Presentation TCT 2017

Association Between Scaffold Under-Expansion and Late Lumen Loss After Bioresorbable Scaffold Implantation - IVUS and Angiographic Insights From the ABSORB Japan Trial

Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Kozo Okada, MD

October 31, 2017

Presentation TCT 2017

ABSORB 3-Year Meta-analysis: 3-Year Outcomes of a Bioresorbable Scaffold Compared to a Metallic DES From an Individual Patient Data Meta-analysis of Four Randomized Trials

Presenter: David P. Faxon, Joseph A. Hill, Ziad A. Ali

October 31, 2017

Presentation TCT 2017

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Gregg W. Stone

October 31, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day Two

Shelley Wood

October 31, 2017

Presentation TCT 2017

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Stephen G. Ellis

October 31, 2017

Advertisement

TCT 94: Safety and Efficacy of the Combo Bioegineered Stent in an All-Comer PCI Cohort - Results From the Mascot Postmarketing Registry

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Standard vs Novel DES and DAPT Duration

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings

XINSORB: A Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Appropriate Patients and DAPT Duration

ABSORB PSP: Impact of Technique on Early and Late Outcomes Following Coronary Bioresorbable Scaffold Implantation

Long-term Absorb BVS Data Continue to Disappoint

TCT 12: Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis Multistudy Registry Results

RECAP: A Sham-Controlled Randomized Trial of Radiation Protection in Patients Undergoing PCI

TCT 9: Absorb Bioresorbable Vascular Scaffold vs Everolimus-Eluting Metallic Stent in Small Vessel Disease -A Propensity Matched Analysis of COMPARE II, RAI, and MAASSTAD-ABSORB Prospective Studies

DEBATE-SFA: A Randomized Trial of a BMS With or Without Cilostazol vs a DES in Patients With Femoropopliteal Disease

TCT 10: Mechanisms of Very Late Bioresorbable Scaffold Thrombosis Assessed by Optical Coherence Tomography - Insights From the International INVEST Registry

RECOVERY: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating vs a Polymer-Free Metallic DES in Patients With Coronary Artery Disease

ABSORB II: 4-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Association Between Scaffold Under-Expansion and Late Lumen Loss After Bioresorbable Scaffold Implantation - IVUS and Angiographic Insights From the ABSORB Japan Trial

ABSORB 3-Year Meta-analysis: 3-Year Outcomes of a Bioresorbable Scaffold Compared to a Metallic DES From an Individual Patient Data Meta-analysis of Four Randomized Trials

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Live From Denver: TCT 2017, Day Two

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content